The Epstein-Barr Virus Drug market was valued at USD 1.65 Billion in 2024 and is expected to reach USD 2.26 Billion by 2032, growing at a CAGR of 4% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.